Clinical Trials Logo

Endometrioma clinical trials

View clinical trials related to Endometrioma.

Filter by:

NCT ID: NCT02047838 Completed - Surgery Clinical Trials

Second Laparoscopic Surgery for Recurrent Unilateral Endometriomas.

Start date: January 2007
Phase: N/A
Study type: Observational

This retrospective case-control study was performed in an Academic centre for the diagnosis and treatment of endometriosis. It included patients with recurrent unilateral endometriomas who were previously operated for the same condition (cases) and patients without recurrency who previously underwent surgery for unilateral endometrioma (controls). The primary outcome of the study was to assess the impact on ovarian reserve of second surgery for recurrent unilateral endometriomas. The evaluation of ovarian reserve was performed by assessing serum anti-mullerian hormone (AMH) level, serum follicle-stimulating hormone (FSH) level, 17-beta estradiol level and antral follicle count (AFC).

NCT ID: NCT01982526 Completed - Surgery Clinical Trials

Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients

Start date: May 2012
Phase:
Study type: Observational [Patient Registry]

Ovarian reserve influenced by many factor but especially cysts like endometrioma. Anti mullerian hormone is recent marker for ovarian reserve. The investigators are searching ovarian reserve pre and post operatively by using antimullerian hormone of endometrioma patient who are operated for their cysts.

NCT ID: NCT01942122 Completed - Endometrioma Clinical Trials

DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis

Start date: October 2015
Phase: Phase 2/Phase 3
Study type: Interventional

This is a 3-arm, prospective, randomized, double-blind, and controlled study of DLBS1442 for the treatment of pain in patients suspected endometriosis. It is hypothesized that the reduction of the composite-pain intensity (as measured by VAS) from baseline to the end of study (week 8th) resulting from administration of DLBS1442, regardless of the dosage regimen, is significantly greater than that of Control. In addition, the administration of DLBS1442 at higher dose also results in significantly greater reduction than that of DLBS1442 at lower dose and of Control.

NCT ID: NCT01808170 Completed - Endometrioma Clinical Trials

Laparoscopic Ovarian Cystectomy of Endometrioma vs Deroofing and Ovarian Reserve

Start date: March 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the impact of laparoscopic ovarian cystectomy versus laparoscopic cyst deroofing on ovarian reserve measured by serum levels of anti mullerian hormone and antral follicle count in patients with endometriomas.

NCT ID: NCT01268930 Completed - Endometrioma Clinical Trials

Comparison of Hemostatic Matrix and Bipolar Coagulation in Surgical Treatment of Endometriomas

Start date: September 2010
Phase: N/A
Study type: Interventional

In this study, impacts of hemostatic matrix and bipolar electrocoagulation on ovarian reserve in women undergoing ovarian endometrioma excision are compared.